57 results on '"FIORETTI M"'
Search Results
2. P218 It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease
3. Halophytes and Salt Tolerant Crops as a Forage Source for Livestock in South America
4. P385 Tailoring induction treatment for children with Crohn’s disease
5. Microwaves for mild postharvest fruit treatment
6. Report of the ICAR Working Group on Milk Recording of Sheep
7. Affordable way of calibrating milkmeters
8. Report of the Working Group on milk recording of sheep
9. Report of the Working Group on Milk Recording of Sheep
10. Le buffle dans l’agriculture et le développement rural en Tunisie
11. Hot Workability Studies of Nimonic 80A Applied to the Net-Shape Forging of Aerofoil Blades
12. Titanium Alloy Turbine Blades Milling with PCD Cutter
13. Hearing loss in very preterm infants: should we wait or treat?
14. Chemical Xenogenization of Experimental Tumors by Antineoplastic Drugs
15. Mechanisms of the Antimetastatic Activity of Prostanoids
16. Cancer Immunotherapy: Preclinical Studies with Triazene Compounds
17. Antimetastatic Activity of a Stable Prostacyclin Analogue: Effect on Platelet Aggregation and Host Immunocompetence in the Mouse
18. P302 Predictors of outcome in children with Crohn’s disease
19. Suboptimal Dishonesty: Rationality in the Absence of Strategic Behavior in Honesty Experiments
20. Effects of potential neurotoxic pesticides on hearing loss: A review
21. Use of allogenic umbilical cord blood for red cells transfusion in premature infants: utopia or reality?
22. Plant growth and survival of five introduced and two native/naturalized perennial grass genotypes exposed to two defoliation managements in arid Argentina
23. Is heel prick as safe as we think?
24. Health risk assessment for exposure to low levels of dangerous chemicals mixtures in research laboratories
25. Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
26. Technology and sustainability for the development of the Caldenal
27. O-096 Phase III study in patients with stage IV non small-cell lungcancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
28. Phase III study in stage IV non-small-cell lung cancer (NSCLC) patients (pts) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
29. Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
30. Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone
31. T cell apoptosis by tryptophan catabolism
32. Effect of including inbreeding coefficients for animal and dam on estimates of genetic parameters and prediction of breeding values for reproductive and growth traits of Piedmontese cattle
33. Milling Titanium Compressor Blades with PCD Cutter
34. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state.
35. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
36. ChemInform Abstract: In vitro Evaluation of the Potential Antitumor Activity of an N‐ Acridyl‐pentanoyloxypyridine‐2‐thione Derivative.
37. [3H]Aniracetam Binds to Specific Recognition Sites in Brain Membranes
38. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.
39. Immunogenic properties of retroviral protein p15e from drug‐treated murine mastocytoma P815
40. Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: Search for serologically defined antigens at the clonal level
41. Pharmacokinetics of rufloxacin once daily in patients with lower respiratory tract infections
42. Genomic aspects of drug-induced xenogenization of murine tumors
43. T-cell subsets, IFN-γ production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells
44. Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative
45. GROWTH AND REJECTION PATTERNS OF MURINE LYMPHOMA CELLS ANTIGENICALLY ALTERED FOLLOWING DRUG TREATMENT IN VIVO
46. Humoral response against murine lymphoma cells xenogenized by drug treatmentin vivo
47. Delayed‐type hypersensitivity to tumor antigens co‐expressed with immunogenic determinants induced by xenogenization
48. Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant
49. Dna methylating activity in murine lymphoma cells xenogenized by triazene derivatives
50. Antilymphoma graft responses in the mouse brain: A study oft‐dependent functions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.